Skip to content

Association of Chinese Visceral Adiposity Index with the Incidence of asymptomatic Hyperuricemia Among Type 2 Diabetes: A Cross-Sectional Study

Association of Chinese Visceral Adiposity Index with the Incidence of asymptomatic Hyperuricemia Among Type 2 Diabetes: A Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090471
Enrollment
Unknown
Registered
2024-09-30
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus and hyperuricemia

Interventions

Sponsors

the Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: hospitalized patients, aged 18 to 80, who were diagnosed with type 2 diabetes mellitus (T2DM) according to the 2023 criteria of the American Diabetes Association (ADA)

Exclusion criteria

Exclusion criteria: (1) a physician-diagnosed history of gout or current gout flare, (2) use of urate-lowering medications, (3) recent acute diabetes complications such as hypoglycemic coma, diabetic ketoacidosis, hyperglycemic hyperosmolar coma, and lactic acidosis, (4) concurrent acute or chronic infections, (5) presence of malignant tumors or autoimmune diseases, and (6) any organ dysfunction or failure

Design outcomes

Primary

MeasureTime frame
Chinese Visceral Adiposity Index(CVAI);

Secondary

MeasureTime frame
weight;height;waist circumference;hip circumference;blood pressure;uric acid;high-density lipoprotein cholesterol;glycated hemoglobin;low-density lipoprotein cholesterol;triglycerides;urine analysis;creatinine;fasting C-peptide;alanine aminotransferase;alkaline phosphatase;?-glutamyltransferase ;aspartate aminotransferase;

Countries

China

Contacts

Public ContactQing Wang

the Affiliated Hospital of Qingdao University

627791946@qq.com+86 186 6180 8627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026